President Trump has set his sights on defunding colleges, singling out some of the world’s wealthiest schools in what critics say is an attack on academic freedom.

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead to the loss of vision, according to the EU medicines regulator. After ...